br />Participants’ disclosures on the top three antibiotic classes that are used other bacteria, in their work on antibiotics or antibiotic resistance. Options: aminocyclitols, aminoglycosides, carbapenems, cephalosporins, monobactams, penicillins, cyclic lipopeptides, folate antagonists, fluoroquinolones, glycopeptides, immunomodulators, ketolides, lincosamides, macrocyclics, macrolides, mycobacterials, nitrofurans, oxazolidinones, peptides, pleuromutilins, polypeptides, pyridopyrimidines, quinolones, streptogramins, sulphonamides, tetracycline, other
21. Novel combinations:
Participants disclosures on the use of novel combinations of antibiotics or antibiotic enhancers (e.g. lactamases).
For those participants who answered ‘yes’ to question x – participants’, disclosures on the research into novel combinations.
23. Single antibiotics or combinations:
Participants disclosures on the percentage (%) of their developments that relate to one, two, three or more than three antibiotics at the same time (enhancers such as lactamase inhibitors are not included). Options1: one antibiotic, two antibiotics together, three antibiotics together, more then three antibiotics, other.
24. Integrated programmes:
Participants disclosures on their work with integrated programmes that give access to information on resistant or susceptible bacterial pathogens in their community, prevalent or emerging antibiotic resistance genes or any other 'surveillance-related' information, to support decisions on the use of specific antibiotics.
25. Current programme:
For those participants who answered ‘yes’ to question 24 – participants disclosures on name of the programme and the geographic area in which it operates.
26. Future integrated programme:
For those participants who answered ‘no’ to question 24
1. General p.10
1.1 Study description
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Related medicine news :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Alternative to antibiotics2
. Zithromax Antibiotics Arrhythmia Lawsuits Help: Resource4thePeople Urges Consumers to Review Dangerous Side Effects Outlined by Medical Experts3
. Low dose antibiotic treatment of C-difficile as effective as high dose in hospital setting4
. Adding blood pressure drug to standard antibiotics speeds up TB treatment5
. World Antibiotic Resistance Market Saw Big Changes in Last Five Years, According to Biopharm Reports Study Available at MarketPublishers.com6
. When prescribing antibiotics, doctors most often choose strongest types of drugs7
. Health Professionals Ask President Obama and FDA to End Non-Therapeutic Use of Antibiotics in Animal Agriculture in a Letter Co-Sponsored by Health Care Without Harm8
. Can You Skip Antibiotics for Urinary Tract Infection?9
. Long-Term Use of Antibiotic May Help Those With COPD10
. University of CA, San Francisco’s Sustainability Task Force Passes Resolution Calling for an End to Purchasing of Meat and Poultry Raised With Non-Therapeutic Antibiotics11
. Variations in antibiotic prescribing of acute rhinosinusitis in united states ambulatory settings